Genomind Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Genomind Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011706
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing products. The company’s product portfolio includes The Genecept Assay, a genetic test developed for clinicians to optimize treatment decisions for their patients with mental illness. Its assay finds patient-specific genetic markers, analyzes key genes and gives treatment decisions. Genomind’s product is used to guide treatment for a range of psychiatric conditions including depression, anxiety, obsessive compulsive disorder, attention deficit disorder, bipolar disorder, post-traumatic stress disorder, autism and schizophrenia. The company also offers pharmacogenetic laboratory testing for psychiatry. It serves clinicians and patients. Genomind is headquartered in King of Prussia, Pennsylvania, the US.

Genomind Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genomind Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genomind Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genomind Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genomind Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Genomind Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Genomind Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Genomind Raises USD11 Million in Venture Financing 10
Genomind Raises USD3 Million in Venture Financing 11
Genomind Raises USD2.2 Million in Venture Financing 12
Genomind Raises USD2 Million in Venture Financing 13
Genomind Raises USD6 Million in Venture Financing 14
Genomind Raises US$5 Million In Venture Financing 15
Genomind Enters Into Licensing Agreement With Emory University 16
Genomind Inc – Key Competitors 17
Genomind Inc – Key Employees 18
Genomind Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Product News 20
02/09/2016: Genetic Testing for Mental Health Approved as New Ally for Military Personnel and Veterans 20
01/19/2016: Clinicians and Patients Gain Powerful Advanced Test for Mental Health as the Genecept Assay Builds on Existing Patient Success 21
Other Significant Developments 22
Jan 09, 2017: Genomind Looks Forward to Growth in New Year as it Reflects on 2016 Accomplishments 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Genomind Inc, Medical Equipment, Key Facts 2
Genomind Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Genomind Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genomind Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genomind Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genomind Inc, Deals By Market, 2011 to YTD 2017 8
Genomind Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Genomind Raises USD11 Million in Venture Financing 10
Genomind Raises USD3 Million in Venture Financing 11
Genomind Raises USD2.2 Million in Venture Financing 12
Genomind Raises USD2 Million in Venture Financing 13
Genomind Raises USD6 Million in Venture Financing 14
Genomind Raises US$5 Million In Venture Financing 15
Genomind Enters Into Licensing Agreement With Emory University 16
Genomind Inc, Key Competitors 17
Genomind Inc, Key Employees 18

★海外企業調査レポート[Genomind Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Otsuka Pharmaceutical Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …
  • Opcon AB (TRENT):企業のM&A・提携動向(発電分野)
    Summary Opcon AB (Opcon) is an energy and environmental technology company that develops, produces and markets systems, and products for ecofriendly, efficient and low-resource energy usage. The company's services include handling systems for biomass, sludge and natural gas, industrial cooling and f …
  • Clarins SA:企業の戦略・SWOT・財務分析
    SummaryClarins SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - D …
  • Westbridge Energy Corporation (WEB):企業のM&A・提携動向(石油・ガス分野)
    Summary Westbridge Energy Corporation (Westbridge Energy) is an oil and gas exploration and production company that produces and discovers hydrocarbons, and carries out the exploration, development and production of oil and natural gas assets in Namibia and the US. Its oil fields include Bivens fiel …
  • Alfa Wassermann SpA:企業のM&A・提携動向(医療分野)
    Summary Alfa Wassermann SpA (Alfa Wassermann) is a pharmaceutical company that research, produces and distributes drugs for human health. The company offers new discoveries in medicine, biology and genomics. It provides self-medication products for treatment of sore throat, headaches, and muscle and …
  • ENTrigue Surgical, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary ENTrigue Surgical, Inc. (ENTrigue) is a medical device company. The company designs, develops and manufactures instruments, materials, and medical devices for the surgical and ENT markets. Its products include septal stapler, hemostatic gel, articulating instruments, sinus dilation system, a …
  • Diamond Electric Mfg. Co., Ltd. (6895):企業財務及び戦略的SWOT分析
    Summary Diamond Electric Mfg. Co., Ltd. (Diamond Electric) is an automobile company that manufactures automobile electronic and home electronic equipment. The company’s automotive electronic equipment comprises ignition devices and electric devices. Its home electronic devices include controllers fo …
  • Glaxo Group Limited (formerly Glaxo Laboratories Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Glaxo Group Limited (formerly G …
  • Infinite Group, Inc. (IMCI):企業概要、財務及び戦略的SWOT分析
    Summary Infinite Group, Inc. (IGI) is an information technology outsourcing company. The company provides IT service and support solutions. Its services include managed services, business process optimization and management, systems engineering, business continuity planning, consulting, cloud comput …
  • FLIR Systems, Inc.:企業の戦略・SWOT・財務分析
    SummaryFLIR Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Navistar Defense, LLC:企業の戦略・SWOT・財務分析
    SummaryNavistar Defense, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Engen Petroleum Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Engen Petroleum Limited Mergers …
  • The University of Tokyo:企業のM&A・提携動向(医療分野)
    Summary The University of Tokyo (UTokyo) is a research university that offers undergraduate, graduate, professional and distance learning programs. The university offers faculty of letters, faculty of science, faculty of agriculture, faculty of economics, faculty of law, faculty of medicine, faculty …
  • CRA International, Inc. (CRAI):企業財務及び戦略的SWOT分析
    Summary CRA International, Inc. (CRA) is a consulting firm that provides economic, financial, and strategic expertise to law firms, corporations, accounting firms and governments. The firm offers services such as accounting and forensic services, antitrust and competition, auctions and competitive b …
  • Fresh Medical Laboratories Inc:企業のM&A・提携動向(医療機器分野)
    Summary Fresh Medical Laboratories Inc (Fresh Medical), formerly Freshmedx is doing business as ProLung, medical device company that offers diagnostic services. The company provides electro pulmonary nodule scanner system is used for the non-invasive early diagnostics of different types of diseases. …
  • SunTrust Banks, Inc.:企業のM&A・提携・投資分析
    SunTrust Banks, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SunTrust Banks, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Vycor Medical Inc (VYCO):企業の財務及び戦略的SWOT分析
    Summary Vycor Medical Inc (Vycor) is a medical device company that designs, develops and markets medical devices for use in neurosurgery. The company provides medical community with neurosurgical and neurotherapeutic solutions. Vycor markets non-invasive, computer-based light stimulation therapy cal …
  • Tech Mahindra Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tech Mahindra Limited Mergers a …
  • TRACON Pharmaceuticals Inc (TCON):企業のM&A・提携動向(医療分野)
    Summary TRACON Pharmaceuticals Inc (TRACON) develops and commercializes innovative therapies for cancer, age-related macular degeneration (AMD) and fibrotic diseases. The company’s has three pipeline product candidates, namely, TRC105, TRC102 and TRC205. TRACON’s lead product TRC105, an anti-endogli …
  • Barclays Bank of Kenya Ltd.:企業の戦略・SWOT・財務分析
    SummaryBarclays Bank of Kenya Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆